Moderna mRNA vaccine almost halves the risk of skin cancer returning
Nature, Published online: 23 October 2026; doi:10.1038/d41586-026-03417-0
Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.相关文章
- How to Design a Guided Camera Flow People Actually Follow2026-11-03
- Fail closed on VPN path changes, Continuity handoffs, and Guided Access / Screen…2026-11-03
- Why a Folding Electric Bike Fits Real Life Better Than You Think2026-11-03
- Over 40% of Pull Requests Now Start With an Agent. Review Them Like It.2026-11-03
- How We Turned GitHub Activity Into a Living 3D Planet2026-11-03
- Kedr: a SACD ISO to FLAC app, written in Cursor2026-11-03